Polaris Venture Management Co. V as of Sept. 30, 2017
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 9 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kala Pharmaceuticals | 37.1 | $43M | 1.9M | 22.84 | |
| Selecta Biosciences (RNAC) | 25.5 | $30M | 1.6M | 18.25 | |
| Fate Therapeutics (FATE) | 8.4 | $9.8M | 2.5M | 3.96 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 7.9 | $9.2M | 1.8M | 5.05 | |
| T2 Biosystems | 6.8 | $7.9M | 1.9M | 4.20 | |
| Pulmatrix | 6.4 | $7.4M | 3.6M | 2.05 | |
| Trevena | 4.5 | $5.2M | 2.1M | 2.55 | |
| Genocea Biosciences | 2.5 | $2.9M | 2.0M | 1.46 | |
| Dare Bioscience (DARE) | 0.9 | $1.0M | 329k | 3.12 |
